Bioxyne Limited (ASX:BXN)
Australia · Delayed Price · Currency is AUD
0.0550
-0.0010 (-1.79%)
Mar 13, 2026, 9:59 AM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Plant Based - UK/EU/JPN/AUS | 3.05M | 5.44M | 5.11M | 463.64K | - | | | | | |
Plant Based - UK/EU/JPN/AUS Growth | -44.00% | 6.40% | 1002.56% | - | - | | | | | |
| 700.92K | 886.91K | 42.56K | - | - | | | | | |
Wholesale - PCC/USA Growth | -20.97% | 1984.14% | - | - | - | | | | | |
Manufacture/sales - Australia | 24.68M | 3.00M | - | - | - | | | | | |
Manufacture/sales - Australia Growth | 722.95% | - | - | - | - | | | | | |
| 872.96K | 334.10K | 182.04K | 4.73K | - | | | | | |
| 161.29% | 83.53% | 3749.40% | - | - | | | | | |
| - | - | - | - | 226.56K | | | | | |
Direct Sales - Asia Growth | - | - | - | - | 132.48% | | | | | |
| - | - | - | - | 65.96K | | | | | |
Wholesale Sales - Asia Growth | - | - | - | - | 383.77% | | | | | |
| - | - | - | - | 1.82M | | | | | |
Wholesale Sales - USA Growth | - | - | - | - | -15.28% | | | | | |
Direct Sales - Australia/NZ | - | - | - | - | 2.39K | | | | | |
Direct Sales - Australia/NZ Growth | - | - | - | - | -55.52% | | | | | |
| 29.30M | 9.66M | 5.34M | 468.37K | 2.11M | | | | | |
| 203.37% | 81.00% | 1039.38% | -77.81% | -12.06% | | | | | |
Source: S&P Global Market Intelligence.
